Ambev
ABEV
318 hedge funds and large institutions have $4.4B invested in Ambev in 2018 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 85 increasing their positions, 140 reducing their positions, and 61 closing their positions.
2,218% more call options, than puts
Call options by funds: $6.44M | Put options by funds: $278K
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
0.05% less ownership
Funds ownership: 7.16% → 7.11% (-0.05%)
4% less funds holding
Funds holding: 331 → 318 (-13)
15% less capital invested
Capital invested by funds: $5.16B → $4.4B (-$763M)
16% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 61
39% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 140
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$48.6M |
| 2 |
MNG
Manning & Napier Group
Fairport,
New York
|
-$44.8M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$38.8M |
| 4 |
JP Morgan Chase
New York
|
-$38.4M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$31.7M |
ABEV Hedge Fund Activity: Q4 2018 in Review
318 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Ambev (ABEV) for Q4 2018, worth a combined $4.4B — down 15% from $5.16B a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of ABEV and 51 opened new positions — a net loss of 10 holders — while 140 trimmed existing stakes and 85 added.
The largest buyer was Credit Suisse, adding an estimated $51.4M. The largest seller was BlackRock, cutting an estimated $48.6M.
- 318 institutional investors held Ambev (ABEV) as of Q4 2018, down from 331 in Q3 2018.
- Funds reported $4.4B of Ambev stock for Q4 2018, down 15% quarter-over-quarter.
- 51 funds opened new Ambev positions in Q4 2018 and 61 closed out, a net change of -10 holders.
- The largest Ambev buyer in Q4 2018 was Credit Suisse, an estimated $51.4M added.
- The largest Ambev seller in Q4 2018 was BlackRock, an estimated $48.6M sold.
Based on aggregated 13F filings for Q4 2018.